Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 54, Issue 6, Pages 1567-1578
Publisher
Springer Nature
Online
2011-03-05
DOI
10.1007/s00125-011-2061-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes and Peripheral Vascular Disease
- (2016) F. Huysman et al. ACTA CHIRURGICA BELGICA
- Signal Transduction via Cannabinoid Receptors
- (2012) George Dalton et al. CNS & Neurological Disorders-Drug Targets
- Neurovascular Protective Effect of FeTPPs in N-Methyl-D-Aspartate Model
- (2010) Mohammed M.H. Al-Gayyar et al. AMERICAN JOURNAL OF PATHOLOGY
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
- (2010) Mohanraj Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
- (2010) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
- (2010) F. Barutta et al. DIABETES
- Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury
- (2010) T. K. Ali et al. DIABETOLOGIA
- Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
- (2010) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFκB signaling pathway and nitric oxide induction in macrophages
- (2010) Miri Brodsky et al. Journal of Inflammation-London
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
- (2009) K. H. Han et al. CARDIOVASCULAR RESEARCH
- CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
- (2009) Partha Mukhopadhyay et al. CARDIOVASCULAR RESEARCH
- Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
- (2009) Ming Zhang et al. Journal of Neuroimmune Pharmacology
- The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats
- (2008) A Schäfer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
- (2008) Koichi Sugamura et al. CIRCULATION
- Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes
- (2008) T. K. Ali et al. DIABETES
- The endocannabinoid system in obesity and type 2 diabetes
- (2008) V. Di Marzo DIABETOLOGIA
- Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
- (2007) P Pacher et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started